Nanjing Zhengda Tianqing 3 generic drug "Tegrelo" officially approved by the State Drug Administration (NMPA) for listing
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
yesterday (July 1), Nanjing Zhengda Tianqing 3 imitationPharmaceutical(http://"Tegrelo" was officially approved by the State Drug Administration (NMPA) for listing, becoming the third approved domesticenterprise signed on the list of the domestic(http://About TegreoTegrelo is a new type of selective small molecule anticoagulant drug, is the first reversible combination, direct effect, oral administration of the new P2Y12 receptor antagonists, clinically mainly used in acute coronary syndrome (ACS) patients and cardiovascular thrombosis prevention and treatmenttegrelo which can effectively reduce the incidence of cardiovascular death, myocardial infarction and stroke, is recommended by the AHA/ACC guidelines, esC guidelines, and Chinese PCI guidelinesAstraZeneca, a former research firm, was approved for the market in July 2011 by the U.SFDA(http://, and the product is called Brilinta, which entered the Chinese market in December 2012
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
